Randomized Study of Nivolumab+Ipilimumab+/- SBRT for Metastatic Merkel Cell Carcinoma

Name: Randomized Study of Nivolumab+Ipilimumab+/- SBRT for Metastatic Merkel Cell Carcinoma
Published: 2017
License: Public Domain

H. Lee Moffitt Cancer Center and Research Institute · 2017

ClinicalTrials.gov · Datasets · License: Public Domain · 2017

Open Source ↗

antibody immunology metastasis nivolumab skin-cancer

merkel cell carcinoma, skin cancer, merkel cell carcinoma (mcc), metastatic, metastasis, stereotactic body radiation therapy (sbrt), immunology, antibody, nivolumab, ipilimumab, metastatic skin cancer, cutaneous

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 811040
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.